Free Trial

BridgeBio Pharma (BBIO) Insider Trading & Ownership

BridgeBio Pharma logo
$43.18 -1.68 (-3.74%)
As of 04:00 PM Eastern

BridgeBio Pharma (NASDAQ:BBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
18.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$697.76M
Get BBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BBIO Insider Buying and Selling by Quarter

BridgeBio Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/24/2025Frank MccormickDirectorSell100,000$44.23$4,423,000.00  
6/10/2025Hannah ValantineDirectorSell4,292$40.00$171,680.00  
5/20/2025Neil KumarCEOSell75,000$33.40$2,505,000.00  
5/19/2025Neil KumarCEOSell26,156$33.33$871,779.48  
5/12/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$34.20$205,200,000.00  
5/2/2025Andrew LoDirectorSell100,000$38.50$3,850,000.00  
5/2/2025Maricel ApuliCAOSell1,026$38.51$39,511.26  
4/22/2025Neil KumarCEOSell75,000$34.11$2,558,250.00  
4/14/2025Andrea EllisDirectorSell10,000$35.00$350,000.00  
4/1/2025Andrea EllisDirectorSell30,000$34.05$1,021,500.00  
3/25/2025Neil KumarCEOSell75,000$36.87$2,765,250.00  
3/5/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$32.96$197,760,000.00  
2/25/2025Brian C StephensonCFOSell8,500$33.19$282,115.00  
2/25/2025Neil KumarCEOSell75,000$33.57$2,517,750.00  
2/19/2025Brian C StephensonCFOSell4,148$36.16$149,991.68  
2/19/2025Neil KumarCEOSell31,543$36.14$1,139,964.02  
1/31/2025Global Investors Lp VikingMajor ShareholderSell3,065,616$34.90$106,989,998.40  
1/28/2025Brian C StephensonCFOSell68,000$36.29$2,467,720.00  
1/28/2025Neil KumarCEOSell326,932$36.29$11,864,362.28  
11/19/2024Brian C StephensonCFOSell4,156$22.41$93,135.96  
11/19/2024Neil KumarCEOSell27,389$22.41$613,787.49  
9/13/2024Genetic Disorder L.P. KkrMajor ShareholderSell5,800,000$25.75$149,350,000.00  
8/19/2024Brian C StephensonCFOSell4,155$24.69$102,586.95  
8/19/2024Neil KumarCEOSell27,389$24.69$676,234.41  
(Data available from 1/1/2013 forward)

BBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at BridgeBio Pharma includes Andrea Ellis, Andrew Lo, Brian C Stephenson, Frank Mccormick, Genetic Disorder L.P. Kkr, Global Investors Lp Viking, Hannah Valantine, Maricel Apuli, Neil Kumar, and Randal W Scott. Learn more on insiders at BBIO.

18.20% of BridgeBio Pharma stock is owned by insiders. Learn more on BBIO's insider holdings.

The following insiders have sold BBIO shares in the last 24 months: Andrea Ellis ($1,371,500.00), Andrew Lo ($3,850,000.00), Brian C Stephenson ($3,744,056.56), Frank Mccormick ($8,629,000.00), Genetic Disorder L.P. Kkr ($552,310,000.00), Global Investors Lp Viking ($159,489,998.40), Hannah Valantine ($282,362.55), Maricel Apuli ($39,511.26), Neil Kumar ($26,986,249.36), and Randal W Scott ($193,840.00).

Insiders have sold a total of 23,621,952 BridgeBio Pharma shares in the last 24 months for a total of $756,896,518.13 sold.



This page (NASDAQ:BBIO) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners